Skip to main content

Advertisement

Log in

Are there racial disparities in utilization and outcomes after total elbow arthroplasty?

  • Original Article - Public Health
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The aim of the study was to assess racial disparities in utilization rates and outcomes after primary total elbow arthroplasty (TEA). We used the National Inpatient Sample from 1998 to 2010, a US national database. Patient characteristics, comorbidity and outcomes after TEA were assessed over time and differences by race studied over the study period. Cochran–Armitage test was used for time trends and logistic regression for the comparison of outcomes by race. In 1998, TEA utilization rate was 0.38/100,000 in Whites and 0.24/100,000 in Blacks (p = 0.002); in 2010, it was 0.91 and 0.59/100,000, respectively (p < 0.0001). White–Black disparity in TEA utilization was significant across 13 years (p = 0.03). Compared with White patients, Black patients undergoing TEA were younger (61.9 vs. 52 years; p < 0.0001), less likely to be female (70.6 vs. 61.4 %; p = 0.0007) and more likely to have rheumatoid arthritis as the underlying diagnosis (13.0 vs. 17.2 %; p = 0.036). Mortality was rare, 0.26 % in Blacks and 0.32 % in Whites (p = 0.83). Discharge to an inpatient facility was higher in White versus Black patients in unadjusted analyses (16.8 vs. 10.4 %; p = 0.003), but in analyses adjusted for age, sex, Deyo–Charlson index and the underlying diagnosis, the differences were no longer significant (p = 0.79). The length of hospital stay greater than the median stay was noted in 29.8 % Whites versus 31.2 % Blacks, respectively (p = 0.61). There was no evidence of White–Black disparity in hospital length of stay in 1998–2000 (p = 0.66) or 2009–2010 (p = 0.59) periods. In this study, we found persisting racial disparities in TEA utilization rates. No White–Black disparities were noted in TEA outcomes, except slight differences in discharge disposition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Bernardino S (2010) Total elbow arthroplasty: history, current concepts, and future. Clin Rheumatol 29(11):1217–1221

    Article  PubMed  Google Scholar 

  2. Gay DM, Lyman S, Do H, Hotchkiss RN, Marx RG, Daluiski A (2012) Indications and reoperation rates for total elbow arthroplasty: an analysis of trends in New York State. J Bone Joint Surg Am 94(2):110–117

    Article  PubMed  Google Scholar 

  3. Angst F, John M, Pap G, Mannion AF, Herren DB, Flury M et al (2005) Comprehensive assessment of clinical outcome and quality of life after total elbow arthroplasty. Arthritis Rheum 53(1):73–82

    Article  PubMed  Google Scholar 

  4. Ashmore AM, Gozzard C, Blewitt N (2007) Use of the Liverpool Elbow Score as a postal questionnaire for the assessment of outcome after total elbow arthroplasty. J Shoulder Elbow Surg 16(3 Suppl):S55–S58

    Article  PubMed  Google Scholar 

  5. Jenkins PJ, Watts AC, Norwood T, Duckworth AD, Rymaszewski LA, McEachan JE (2013) Total elbow replacement: outcome of 1146 arthroplasties from the Scottish Arthroplasty Project. Acta Orthop 84(2):119–123

    Article  PubMed Central  PubMed  Google Scholar 

  6. Little CP, Graham AJ, Karatzas G, Woods DA, Carr AJ (2005) Outcomes of total elbow arthroplasty for rheumatoid arthritis: comparative study of three implants. J Bone Joint Surg Am 87(11):2439–2448

    Article  PubMed  Google Scholar 

  7. Day JS, Lau E, Ong KL, Williams GR, Ramsey ML, Kurtz SM (2010) Prevalence and projections of total shoulder and elbow arthroplasty in the United States to 2015. J Shoulder Elbow Surg 19(8):1115–1120

    Article  PubMed  Google Scholar 

  8. Singh JA, Lu X, Rosenthal GE, Ibrahim S, Cram P (2013) Racial disparities in knee and hip total joint arthroplasty: an 18-year analysis of national medicare data. Ann Rheum Dis 73(12):2107–2115

    Article  PubMed Central  PubMed  Google Scholar 

  9. STROBE Statement (2007) Strengthening the reporting of observational studies in epidemiology. Link: http://www.strobe-statement.org/fileadmin/Strobe/uploads/checklists/STROBE_checklist_v4_cohort.pdf. University of Bern, Bern, Germany [09/06/2012]

  10. Jain NB, Higgins LD, Guller U, Pietrobon R, Katz JN (2006) Trends in the epidemiology of total shoulder arthroplasty in the United States from 1990–2000. Arthritis Rheum 55(4):591–597

    Article  PubMed  Google Scholar 

  11. Cram P, Lu X, Kaboli PJ, Vaughan-Sarrazin MS, Cai X, Wolf BR et al (2011) Clinical characteristics and outcomes of Medicare patients undergoing total hip arthroplasty, 1991–2008. JAMA 305(15):1560–1567

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Cram P, Lu X, Kates SL, Singh JA, Li Y, Wolf BR (2012) Total knee arthroplasty volume, utilization, and outcomes among Medicare beneficiaries, 1991–2010. JAMA 308(12):1227–1236

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Katz JN, Losina E, Barrett J, Phillips CB, Mahomed NN, Lew RA et al (2001) Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the United States medicare population. J Bone Joint Surg Am 83-A(11):1622–1629

    CAS  PubMed  Google Scholar 

  14. Singh JA, Ayub S (2010) Accuracy of VA databases for diagnoses of knee replacement and hip replacement. Osteoarthr Cartil 18(12):1639–1642

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This material is the result of work supported by the resources and use of facilities at the Birmingham VA Medical Center, Alabama, USA. J.A.S. is also supported by grants from the Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs), National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS), National Institute of Aging (NIA) and National Cancer Institute (NCI).

Conflict of interest

There are no financial conflicts related directly to this study. J.A.S. has received research and travel grants from Takeda and Savient and consultant fees from Savient, Takeda, Allergan and Regeneron. R.R. has no conflicts.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jasvinder A. Singh.

Additional information

Disclaimer The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the US government.

The study was approved by the Institutional Review Board (IRB) at the University of Alabama at Birmingham, Birmingham.

The data are collected by the Mayo Clinic for clinical care of patients and maintained in an internal Mayo database that patients have provided permission to Mayo Clinic for analyses. We will make available these data to colleagues for any analyses, once appropriate approvals have been obtained from the IRBs and the data transfer is compliant with the HIPAA and appropriate permissions have been obtained from all involved parties.

Appendix

Appendix

See Table 5.

Table 5 Race-specific time trends in characteristics of patients undergoing TEA from 1998 to 2010

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singh, J.A., Ramachandran, R. Are there racial disparities in utilization and outcomes after total elbow arthroplasty?. Rheumatol Int 35, 1479–1487 (2015). https://doi.org/10.1007/s00296-015-3252-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-015-3252-y

Keywords

Navigation